Online citations, reference lists, and bibliographies.

Laboratory And Clinical Basis For Hyperthermia As A Component Of Intracavitary Chemotherapy

Paul H Sugarbaker
Published 2007 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Intraoperative chemotherapy with heat has been identified as a treatment option for patients with cancer spread to peritoneal surfaces. This treatment modality is viewed as a supplement to several other treatments for this group of patients including cytoreductive surgery, systemic chemotherapy, early postoperative intraperitoneal chemotherapy, and long-term bidirectional chemotherapy. The pharmacologic basis for using heat to supplement chemotherapy effects are related to the increased penetration of chemotherapy into tumor with hyperthermia, the delayed clearance of chemotherapy from the peritoneal cavity after direct instillation, and an increased cytotoxicity that has been documented with selected chemotherapy agents. Data to support the use of perioperative hyperthermic intraperitoneal chemotherapy with mucinous appendiceal carcinomatosis comes from a large number of single institution phase II studies. Also, peritoneal and pleural mesothelioma are benefited. In colon cancer carcinomatosis, large phase II multi-institutional trials and a single phase III trial documented an increased median survival of these patients from approximately 1 year to over 2 years. Prophylaxis against peritoneal carcinomatosis in gastric cancer has been demonstrated in phase III trials. In ovarian cancer the rationale for this treatment remains large but its current application is limited. Much work needs to be done to identify a proper clinical perspective on hyperthermia used with chemotherapy in patients with peritoneal surface malignancy.
This paper references
10.1080/026567399285765
For the clinical application of thermochemotherapy given at mild temperatures.
Muneyasu Urano (1999)
10.1007/s00280-006-0229-2
Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor
Faheez Mohamed (2006)
10.1159/000011847
Heated Intraoperative Intraperitoneal Mitomycin C and Early Postoperative Intraperitoneal 5-Fluorouracil: Pharmacokinetic Studies
Pierre Jacquet (1998)
10.1200/JCO.2004.10.012
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
Olivier Glehen (2004)
10.1007/978-3-642-82955-0_5
Hyperthermia and drugs.
R Engelhardt (1987)
10.1200/jco.2005.23.16_suppl.7175
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for malignant peritoneal mesothelioma (MPM)
Robert N. Taub (2005)
10.1200/JCO.2005.04.6813
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
William Gleason Richards (2006)
Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases.
Jane B. Marmor (1979)
Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.
Robert F. Ozols (1979)
10.1007/978-3-642-83260-4_23
Interaction of hyperthermia and chemotherapy.
O. J. Dahl (1988)
10.1002/1097-0142(19830915)52:6<983::AID-CNCR2820520609>3.0.CO;2-W
Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumor (BT4A) in vivo.
O. J. Dahl (1983)
10.1111/j.1445-2197.2007.04131_14.x
Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database.
Tristan D. Yan (2007)
10.1152/ajprenal.1985.248.3.F413
A distributed model of peritoneal-plasma transport: analysis of experimental data in the rat.
Michael Francis Flessner (1985)
10.1002/jso.20117
Docetaxel and hyperthermia: factors that modify thermal enhancement.
Faheez Mohamed (2004)
10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V
Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors.
David Z. J. Chu (1989)
10.1200/JCO.2001.19.4.1001
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Gr
Margaret R Markman (2001)
10.1016/S1055-3207(03)00050-4
Intraperitoneal chemotherapy with mitoxantrone in malignant ascites.
Karl H. Link (2003)
10.1097/00000658-199402000-00002
Pseudomyxoma Peritonei Long‐Term Patient Survival with an Aggressive Regional Approach
David B. Gough (1994)
10.1007/s002800051093
Successful management of microscopic residual disease in large bowel cancer
Paul H Sugarbaker (1999)
10.1634/theoncologist.10-2-112
Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy.
Paul H Sugarbaker (2005)
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
Gerrit Los (1992)
10.1200/JCO.2003.04.187
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Vic J. Verwaal (2003)
10.1200/JCO.2003.04.150
Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
Andrew L. Feldman (2003)
10.1200/JCO.2006.07.1142
Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.
Tristan D. Yan (2006)
10.1245/ASO.2006.03.079
Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous Malignancy
Paul H Sugarbaker (2006)
10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study.
B Sadeghi (2000)
10.1097/01.AOG.0000209375.75503.38
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Roopa Hariprasad (2006)
10.1007/s00268-001-0067-7
Indications for Early Postoperative Intraperitoneal Chemotherapy of Advanced Gastric Cancer: Results of a Prospective Randomized Trial
Wansik Yu (2001)
Metastatic inefficiency: Causes and consequences
L. Weiss (1986)
10.1177/145749690309200213
New Perspectives in the Management of Colorectal Cancer: What about Peritoneal Carcinomatosis?
Olivier Glehen (2003)
10.1016/0163-7258(89)90038-7
Hyperthermic oncology: current biology, physics and clinical results.
John L. Meyer (1989)
10.1016/j.ejso.2006.03.012
Comprehensive management of diffuse malignant peritoneal mesothelioma.
Paul H Sugarbaker (2006)
10.1002/bjs.4516
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
Vic J. Verwaal (2004)
10.1007/s002800050721
Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model
Pierre Jacquet (1997)
10.1097/00000658-199501000-00004
Peritonectomy Procedures
Paul H Sugarbaker (2003)
10.1093/ANNONC/MDM137
Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer.
Lana Bijelić (2007)
New standard of care for appendiceal epithelial malignancies and pseudomyxoma peritonei syndrome
PH Sugarbaker (2006)
Metaanalysis of intraperitoneal chemotherapy for gastric cancer
DZ Xu (2004)
10.1046/j.1365-2168.2002.02274.x
Peritoneal carcinomatosis from colorectal cancer.
D. G. Jayne (2002)
10.1097/00000478-200308000-00006
Appendiceal Mucinous Neoplasms: A Clinicopathologic Analysis of 107 Cases
Joseph Misdraji (2003)
10.1023/A:1023791229361
Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread
C. Pablo Carmignani (2004)
10.1007/978-1-4613-1247-5_6
Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology.
Paul H Sugarbaker (1996)
10.1245/ASO.2006.03.045
Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion
Marcello Deraco (2006)
Timing of combined hyperthermia and 1,3-bis(2-chloroethyl)-1-nitrosourea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumours.
Olav Mella (1985)
Interactions of hyperthermia and drugs: treatments and probes.
George M. Hahn (1982)
10.1056/NEJM199612263352603
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
David S. Alberts (1996)
10.1097/01.sla.0000152015.76731.1f
Long-term Survival Following Treatment of Pseudomyxoma Peritonei: An Analysis of Surgical Therapy
Thomas J Miner (2005)
10.1002/jso.20370
An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
Paul H Sugarbaker (2005)
10.1097/00000658-199803000-00009
Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker.
Astrid Schott (1998)
First-line intraperitoneal cisplatin-paclitaxel and intravenous ifosfamide in Stage IIIc ovarian epithelial cancer.
Benjamin Zylberberg (2004)
10.1002/bjs.4399
Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin.
Dominique M Elias (2004)
10.1007/s10434-999-0727-7
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy
Paul H Sugarbaker (1999)



This paper is referenced by
10.1016/j.ctrv.2011.10.006
Diffuse malignant peritoneal mesothelioma--an update on treatment.
Peyman Mirarabshahii (2012)
10.1245/s10434-019-07495-5
Elevated Maximum Core Body Temperature During Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is Associated with Increased Postoperative Complications
Ryan J Hendrix (2019)
10.1007/s11912-018-0703-0
Peritoneal Metastases from Gastrointestinal Cancer
Paul H Sugarbaker (2018)
Chimiohyperthermie intrapéritonéale à l’oxaliplatinedans le traitement de la carcinose péritonéaled’origine appendiculaire
Éric Marcotte (2010)
A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil : pseudomixoma peritonei , appendiceal tumors and malignant peritoneal mesothelioma
Paulo Benigno Pena Batista (2017)
Intraperitoneal Chemotherapy For The Treatment Of Malignant Peritoneal Mesothelioma
Binsheng Zhao (2017)
10.1002/jso.21746
Differential effect of hyperthermia on nerves and smooth muscle of the mouse ileum.
Shoshana Burke (2011)
10.21037/3731
Modulation of intraperitoneal (IP) chemotherapy in ovarian cancer
Maryann J. Kwa (2015)
10.1007/978-94-024-1167-6
Retroperitoneal Tumors
Cheng-Hua Luo (2018)
Consideraciones anestésicas para citorreducción y perfusión intraoperatoria intraperitoneal de quimioterapia hipertérmica
Alejandro Mayoral-Silva (2013)
10.1088/0957-4484/23/50/505706
Magnetocaloric effect in magnetothermally-responsive nanocarriers for hyperthermia-triggered drug release.
Jianbo Li (2012)
10.1080/02656736.2017.1300944
Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomyxoma peritonei
Nina Ashraf-Kashani (2017)
10.1188/13.CJON.84-87
Heated intraperitoneal chemotherapy in appendiceal cancer treatment.
Robin Cianos (2013)
10.18632/oncotarget.22062
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
Zi-yi Zhao (2017)
10.1097/GCO.0b013e328333d1e2
Use of combined radiation and hyperthermia for gynecological cancer
Martine Franckena (2010)
10.17116/ONKOLOG2017664-13
Treatment of patients with gastric cancer and peritoneal carcinomatosis: current views and perspectives
В. М. Хомяков (2017)
10.1007/s00595-013-0500-1
Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case
Emel Canbay (2013)
10.1159/000329458
Targeted Iron Oxide Nanocomplex as a Theranostic Agent for Cancer
Esther H Chang (2011)
10.1016/j.soc.2012.07.013
Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy.
Kurt van der Speeten (2012)
10.1631/jzus.B1400224
Cisplatin combined with hyperthermia kills HepG2 cells in intraoperative blood salvage but preserves the function of erythrocytes
Jin-ting Yang (2015)
10.1007/978-1-4939-1423-4_21
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Reese W Randle (2015)
10.1590/0100-69912017005016
A proposal of Brazilian Society of Surgical Oncology (BSSO/SBCO) for standardizing cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma
Thales Paulo Batista (2017)
10.1007/978-3-030-28891-4_7
Rationale Behind HIPEC/Molecular and Genetic Considerations in HIPEC
Jula Veerapong (2020)
10.1016/j.jss.2018.07.063
Murine Models of Intraperitoneal Perfusion for Disseminated Colorectal Cancer.
Eleanor McCabe-Lankford (2019)
10.1111/j.1479-828X.2010.01209.x
Second-line treatment of first relapse recurrent ovarian cancer.
Terence C Chua (2010)
10.1007/s00432-009-0667-4
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results
Terence C Chua (2009)
10.3978/j.issn.2078-6891.2015.105
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy.
Paul H Sugarbaker (2016)
10.1245/s10434-014-4075-x
Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
Maria F. Nunez (2014)
10.1002/bjs5.93
Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy
A Tzivanakis (2018)
Clinical and Experimental Studies in Peritoneal Metastases from Gastric Cancer
Bo Hultman (2013)
10.1159/000354134
Surgical Approach Including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Metastasis
Gabriel Glockzin (2013)
10.1097/PPO.0b013e3181a58d95
Pharmacokinetics and Pharmacodynamics of Perioperative Cancer Chemotherapy in Peritoneal Surface Malignancy
Kurt van der Speeten (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar